期刊文献+

耐碳青霉烯类鲍曼不动杆菌6种基因及ISAbal插入序列的研究 被引量:5

Research on six genes and insertion sequence ISAbal of carbopenems-resistant Acinetobacter baumannii
下载PDF
导出
摘要 目的研究耐碳青霉烯类鲍曼不动杆菌(CRAB)的基因型特点和与插入序列ISAbal的关系,探讨其耐药机制。方法收集CRAB 70株(非重复)和碳青霉烯类敏感鲍曼不动杆菌10株,采用2-巯基丙酸抑制试验检测金属β-内酰胺酶(MBLs);采用多重聚合酶链反应(PCR)扩增blaIMP、blaVIM、blaOXA-23、blaOXA-24、blaOXA-51、blaOXA-58、ISAbalOXA-23,扩增产物DNA测序进行比对。结果 70株CRAB 2-巯基丙酸与头孢他啶协同试验全部为阴性(即MBLs阴性),用7对特异性引物对70株CRAB和10株敏感菌进行PCR扩增,所有CRAB均携带blaOXA-23、blaOXA-51,未检出blaOXA-24;1株含有blaOXA-58;80株均不携带blaIMP和blaVIM;插入序列ISAbalOXA-2370株CRAB均有表达,敏感菌均不表达。结论 CRAB的主要耐药基因是blaOXA-51和blaOXA-23;另外,blaOXA-23上游都存在插入序列ISAbal。鲍曼不动杆菌的耐药性与MBLs、blaOXA-24、blaOXA-58无相关性。 Objective To study the relationship between the genotype characteristics and insertion sequence lSAbal of carbopenems-resistant Acinetobacter baumannii( CRAB), and investigate the drug-resistant mechanism. Methods A total of 70 strains of CRAB (no repeat strains) and 10 strains of carbopenems-sensitive Acinetobacter baumannii were collected. Metalloenzyme beta-lactamase (MBLs) were detected by 2-mereaptopropionic acid inhibition test. The blaIMP, blaVIM, blaoxA-23, blaoxA-24, blaoxA-51, blaoxA-58 and ISAbaloxA-23 were amplified by multiplex polymerase chain reaction (PCR). The amplified products were measured for DNA sequence. Results The synergy tests were negative (MBLs negative ) by 2-mereaptopropionie acid and ceftazime in 70 strains of CRAB. Through 7 pairs of specific primers, 70 strains of CRAB and 10 strains of carbopenems-sensitive Acinetobacter baumannii were determined for PCR amplification. All the CRAB strains carried blaoxA-23 and blaoxA-51, but blaoxA-24 was never detected. Only 1 strain carried blaoxA.58, and the 80 strains did not carry blaiMP and blawM. In addition, all the CRAB strains carried insertion sequence ISAbaloxA-23, however, all the sensitive strains did not carry. Conclusions Major genes are blaoxA-51 and blaoxA-23 in the CRAB strains. Insertion sequence ISAbal is located in the upstream of blaoxA-23. There is no correlation among drug-resistance of Acinetobacter baumannii to MBLs, blaoxA-24 and blaoxA-58.
出处 《检验医学》 CAS 2012年第9期749-753,共5页 Laboratory Medicine
关键词 鲍曼不动杆菌 金属酶 碳青霉烯酶 基因型 插入序列ISAbal Acinetobacter baumannii Metalloenzyme Carbopenem Genotype Insertion sequence ISAbal
  • 相关文献

参考文献8

  • 1俞云松.多药耐药鲍曼不动杆菌——21世纪革兰阴性菌的“MRSA”[J].中华临床感染病杂志,2009,2(2):65-68. 被引量:93
  • 2中华检验医学杂志CLSI临床检验标准编译小组.抗菌药物敏感性试验执行标准[J].中华检验医学杂志,2010,33(特刊):40-55.
  • 3Bou G,Oliver A,Martfnez-Beltrdn J. OXA-24 a novelclass D beta-lactamase with carbapenemase activity inan Acinetobacter baumannii clinical strain [ J ]. Anti-microb Agents Chemother, 2000,44 (6 ) ; 1556-1561.
  • 4H^ritier C, Dubouix A, Poirel L, et al. A nosocomialoutbreak of Acinetobacter baumannii isolates expressingthe carbapenem-hydrolysing oxacillinase OXA-58 [ J].J Antimicrob Chemother, 2005,55(1) : 115-118.
  • 5Brown S, Young HK , Amyes SG. Charaeterisationof OX A-51,a novel class D carbapenemase found ingenetically unrelated clinical strains of Acinetobacterbaumannii from Argentina[ J]. Clin Microbiol Infect,2005,11(1) :15-23.
  • 6Peleg AY,Seifert H, Paterson DL. Acinetobacter bau-mannii :emergence of a successful pathogen [ J ]. ClinMicrobiol Rev, 2008,21(3) :538-582.
  • 7Corvee S,Caroff N,Espaze E,et al. AmpC cephalospo-rinase hyperproduction in Acinetobacter baumanniiclinical strains[ J]. J Antimicrob Chemother, 2003 ,52(4) :629-635.
  • 8Turton JF, Ward ME, Woodford N, et al. The role ofISAbal in expression of OXA carbapenemase genes inAcinetobacter baumannii [ J ]. FEMS Microbiol Lett,2006,258(1) :72-77.

共引文献92

同被引文献76

  • 1胡芳,付英梅,马佳毓.整合子与细菌耐药性[J].微生物学杂志,2006,26(2):79-81. 被引量:4
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3Gogou V,Pournaras S,Giannouli M,et al. Evolution of multidrug- resistant Acinetobaeter baumannii elonal lineages:a 10 year studyin Greece (2000-09) [J]. J Antimicrob Chemother, 2011,66 (12) 2767-2772.
  • 4Zarrilli R, Pournaras S, Giannouli M, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages[J]. Int J Antimicrob Agents,2013,41(1) :11-19.
  • 5Zhao WH, Hu ZQ. Acinetobacter: a potential reservoir and dis- penser for 13-1actamases[J]. Crit Rev Microbiol, 2012,38 (1) : 30- 51.
  • 6Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii:mechanisms and epidemiology['J]. Clin Microbiol In- fect,2006,12(9) :826-836.
  • 7Lee K,Yum JH,Yong D,et al. Novel acquired metallo-beta-lacta- mase gene, bla (SIM-1), in a class 1 integron from Acinetobaeter baumannii clinical isolates from Korea [J]. Antimicrob Agents Chemother, 2005,49 (11) : 4485-4491.
  • 8Migliavaeca R, Espinal P, Principe L, et al. Characterization of re- sistance mechanisms and genetic relatedness of carbapenem-resist- ant Acinetobacter baumannii isolated from blood, Italy[J]. Diagn Microbiol Infect Dis, 2013,75(2) : 180-186.
  • 9Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and ge- netics of class D 13-1actamases[J]. Antimierob Agents Chemother, 2010,54(1) :24-38.
  • 10Akers KS,Chaney C,Barsoumian A,et al. Aminoglycoside resist- ance and susceptibility testing errors in acinetobacter baumannii- calcoaceticus complex[J]. J Clin Microbiol, 2010, 48 (4) : 1132- 1138.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部